Varian Medical Systems EBITDA margin
Was ist das EBITDA margin von Varian Medical Systems?
EBITDA margin von Varian Medical Systems, Inc. ist 16.82%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu Varian Medical Systems
Was macht Varian Medical Systems?
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Unternehmen mit ebitda margin ähnlich Varian Medical Systems
- Koninklijke DSM NV hat EBITDA margin von 16.81%
- Koninklijke DSM NV hat EBITDA margin von 16.81%
- Fineotex Chemical hat EBITDA margin von 16.81%
- Seagate Technology plc hat EBITDA margin von 16.82%
- Emperor International hat EBITDA margin von 16.82%
- Orla Mining hat EBITDA margin von 16.82%
- Varian Medical Systems hat EBITDA margin von 16.82%
- Varian Medical Systems hat EBITDA margin von 16.82%
- Hi Sun Technology (China) hat EBITDA margin von 16.82%
- Tecan hat EBITDA margin von 16.82%
- Richards Packaging Income Fund hat EBITDA margin von 16.83%
- Etsy Inc hat EBITDA margin von 16.83%
- Mahindra Holidays & Resorts India hat EBITDA margin von 16.83%